Bml Capital Management, LLC Atea Pharmaceuticals, Inc. Transaction History
Bml Capital Management, LLC
- $124 Billion
- Q1 2025
A detailed history of Bml Capital Management, LLC transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Bml Capital Management, LLC holds 7,609,812 shares of AVIR stock, worth $27.7 Million. This represents 18.41% of its overall portfolio holdings.
Number of Shares
7,609,812
Previous 7,608,312
0.02%
Holding current value
$27.7 Million
Previous $25.5 Billion
10.73%
% of portfolio
18.41%
Previous 15.83%
Shares
8 transactions
Others Institutions Holding AVIR
# of Institutions
109Shares Held
48.3MCall Options Held
3.4KPut Options Held
14.5K-
Black Rock Inc. New York, NY9.12MShares$33.2 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA4.8MShares$17.5 Million0.93% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.73MShares$17.2 Million0.0% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA2.49MShares$9.05 Million2.49% of portfolio
-
Geode Capital Management, LLC Boston, MA1.98MShares$7.2 Million0.0% of portfolio
About Atea Pharmaceuticals, Inc.
- Ticker AVIR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 83,258,600
- Market Cap $303M
- Description
- Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...